Avantor, Inc.

What they do

Avantor distributes consumables and equipment through its VWR channel and manufactures proprietary products including J.T. Baker chemicals, Masterflex fluid handling, and NuSil silicone for medical implants. The company serves over 300,000 customer locations in approximately 180 countries, with more than 85% of net sales from recurring product and service offerings.

Revenue drivers

• VWR Distribution & Services — Distributes a broad range of consumables, equipment, and services to laboratories globally; second quarter 2026 net sales of $1,240.5 million, up 2.7% reported and 1.7% organic.
• Bioscience & Medtech Products — Manufactures proprietary bioprocessing materials, chemicals, silicone, and single-use systems; second quarter 2026 net sales of $451.8 million, down 5.1% reported and 5.6% organic.
• Materials & consumables — Core product category including ultra-high purity chemicals, reagents, lab supplies, and single-use assemblies, driving recurring revenue.
• Services & specialty procurement — Onsite lab and production services, as well as customer procurement services, contribute to customer stickiness and recurring revenue.

Recent performance

For Q2 2026, Avantor reported net sales of $1,692.3 million, up 0.5% year-over-year, with organic decline of 0.4% due to a 0.9% positive currency impact. Net income fell to $38.1 million from $64.7 million, while adjusted EBITDA was $254.3 million and adjusted EPS was $0.21. Operating cash flow was $178.2 million and free cash flow $142.8 million, used to repay $112.1 million of debt.

Strategy

Management's 'Revival' program focuses on improving customer service and driving improved business performance. The company revised its segment reporting in 2026 to Bioscience & Medtech Products and VWR Distribution & Services, aligning with how the CEO assesses performance. They are pursuing operational and strategic actions to improve VWR Distribution performance, given goodwill impairment risk. Free cash flow is prioritized for debt repayment to strengthen the balance sheet.

Risks

• Goodwill impairment risk — The VWR Distribution reporting unit had fair value exceeding carrying value by only a limited margin in Q1 2026; further decline in market capitalization or projections could trigger a material non-cash impairment charge.
• Supply chain and inflation — Ongoing challenges sourcing products and raw materials, plus inflationary pressures across cost categories, could continue to adversely impact margins despite pricing and productivity measures.
• Trade policy changes — Recent U.S. trade policy changes reduced some tariff pressures but uncertainty remains, and future changes could negatively affect results.
• Foreign currency fluctuation — Movement of the U.S. dollar against functional currencies, especially the Euro, has caused significant variability and may continue to do so.

Outlook

Avantor raised its fiscal 2026 guidance: organic revenue growth now -0.5% to +0.5% (from -2.5% to -0.5%), adjusted EPS $0.80-$0.83, and free cash flow $500M-$550M unchanged. Adjusted EBITDA margin guidance remains 14.8%-15.3%. Management expects continued improvement from the Revival program and VWR Distribution to sustain positive organic growth.